CLINICAL_TRIALS
research
· 2013-01-01
Clinical Trial Update: Glucocorticoids in Patients With IgG4-RD [Phase 2, Phase 3]
Summary
This entry provides an update on a Phase 2/Phase 3 trial evaluating glucocorticoids for IgG4-related disease. The current status is UNKNOWN.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Peking Union Medical College Hospital | Conditions: IgG4-related Disease | Phase 2, Phase 3 | Status: UNKNOWN